Clinical Trial Update: Neuroprotection With Phenytoin in Optic Neuritis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing phenytoin for neuroprotection in optic neuritis (with participants also having multiple sclerosis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Optic Neuritis

Drugs mentioned

• Phenytoin (Phenytoin)

Snippet

Sponsor: University College, London | Conditions: Optic Neuritis, Multiple Sclerosis | Phase 2 | Status: COMPLETED